Prognostic values of the miR-17-92 cluster and its paralogs in colon cancer

Journal of Surgical Oncology

Volumn 106, Issue 3, 2012, Pages 232-237

  Yu, Ge ^a   Tang, Jian Qiang ^a   Tian, Mao Lin ^a   Li, Hui ^a   Wang, Xin ^a   Wu, Tao ^a   Zhu, Jing ^a   Huang, Shan Jun ^a   Wan, Yuan Lian ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

colon cancer; miR 17 92 cluster; prognosis

Indexed keywords

MICRORNA; MICRORNA 106A; MICRORNA 106B; MICRORNA 17; MICRORNA 18A; MICRORNA 19A; MICRORNA 19B; MICRORNA 20A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84861607077     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22138     Document Type: Article

References (33)

1. Jemal A, Bary F, Center MM, et al.: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Rodriguez-Bigas MA, Hoff P, Crane CH,: Carcinoma of the colon and rectum. In:, Kufe DW, Bast RC, Hait WN, et al., editors. Holland-Frei Cancer Medicine 7, 7th edition. Hamilton, Ontario: BC Decker, Inc.; 2006. pp 1369-1391.
3. Wightman B, Ha I, Ruvkun G,: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993; 75: 855-862.
4. Esquela-Kerscher A, Slack FJ,: OncomirsmicroRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
5. Brennecke J, Hipfner DR, Stark A, et al.: Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 2003; 113: 25-36.
6. Liu W, Mao SY, Zhu WY,: Impact of tiny miRNAs on cancers. World J Gastroenterol 2007; 13: 497-502.
7. Merkel O, Hamacher F, Laimer D, et al.: Identification of differential, functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+, ALK- anaplastic large-cell lymphoma. Proc Natl Acad Sci USA 2010; 107: 16228-16233.
8. Volinia S, Calin GA, Liu CG, et al.: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-2261.
9. Cummins JM, He Y, Leary RJ, et al.: The colorectal microRNAome. Proc Natl Acad Sci USA 2006; 103: 3687-3692.
10. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, et al.: MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 2009; 101: 707-714.
11. Navarro A, Bea S, Fernandez V, et al.: MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas. Cancer Res 2009; 69: 7071-7078.
12. Hayashita Y, Osada H, Tatematsu Y, et al.: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005; 65: 9628-9632.
13. Greene FL, Page DL, Fleming ID, et al.: AJCC Cancer Staging Manual, 6th edition. New York, NY: Springer; 2002.
14. Livak KJ, Schmittgen TD,: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
15. Atkin WS, Edwards R, Kralj-Hans I, et al.: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicentre randomised controlled trial. Lancet 2010; 375: 1624-1633.
16. Hurwitz H, Fehrenbacher L, Novotny W, et al.: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.
17. Bardelli A, Siena S,: Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. J Clin Oncol 2010; 28: 1254-1261.
18. Calin GA, Ferracin M, Cimmino A, et al.: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793-1801.
19. Bloomston M, Frankel WL, Petrocca F, et al.: MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas chronic pancreatitis. JAMA 2007; 297: 1901-1908.
20. Yanaihara N, Caplen N, Bowman E, et al.: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198.
21. Lu J, Getz G, Miska EA, et al.: MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
22. Monzo M, Navarro A, Bandres E, et al.: Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res 2008; 18: 823-833.
23. Lanza G, Ferracin M, Gafà R, et al.: mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 2007; 6: 54.
24. Schetter AJ, Leung SY, Sohn JJ, et al.: MicroRNA expression profiles associated with prognosis, therapeutic outcome in colon adenocarcinoma. JAMA 2008; 299: 425-436.
25. Mendell JT,: miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008; 133: 217-222.
26. Ota A, Tagawa H, Karnan S, et al.: Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 2004; 64: 3087-3095.
27. Northcott PA, Fernandez LA, Hagan JP, et al.: The miR-17/92 polycistron is upregulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res 2009; 69: 3249-3255.
28. Venturini L, Battmer K, Castoldi M, et al.: Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 2007; 109: 4399-4405.
29. Miyoshi K, Miyoshi T, Siomi H,: Many ways to generate microRNA-like small RNAs: Non-canonical pathways for microRNA production. Mol Genet Genomics 2010; 284: 95-103.
30. Guil S, Caceres JF,: The multifunctional RNA binding protein hnRNP A1 is required for processing of miR-18a. Nat Struct Mol Biol 2007; 14: 591-596.
31. He L, Thomson JM, Hemann MT, et al.: A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-833.
32. Tanzer A, Stadler PF,: Molecular evolution of a microRNA cluster. J Mol Biol 2004; 339: 327-335.
33. Valladares-Ayerbes M, Blanco M, Haz M, et al.: Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer. Int J Oncol 2011; 39: 1253-1264.